Valuing the benefits of new anticancer drugs

Authors

Nicola Lawrence, University of Sydney
Glenn P. Salkeld, University of WollongongFollow
Martin R. Stockler, University of Sydney
Deme J. Karikios, University of Sydney

RIS ID

115361

Publication Details

Lawrence, N. J., Salkeld, G., Stockler, M. R. & Karikios, D. (2016). Valuing the benefits of new anticancer drugs. Medical Journal of Australia, 204 (11), 403-405.

Abstract

Improvements in survival and cancer-related symptoms must be weighed up against treatment-related adverse effects and financial burden.